All News

Company releases data at the American Society of Clinical Oncology Annual Meeting 2022 showing that the drug is well-tolerated in patients with solid tumors.

There are a huge number of medical facilities in Ukraine that run international clinical trials, with the FDA noting that more than 250 drugs and devices were undergoing clinical research in Ukraine.

The new study analyzed KSHV’s latent-lytic switch, a process in which the virus exits its dormancy state to replicate in the host cell.

The safety profile of valoctocogene roxaparvovec in the phase 1/2 study was consistent with previously reported data, with no delayed-onset treatment-related adverse events (AEs).

These real-world findings help support the use of DPI in patients at increased risk of vascular events.

Pegfilgrastim-pbbk is the third oncology biosimilar developed by Amneal to gain FDA approval this year.

Ritonavir (Norvir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

OTC Sciatica Therapy helps relieve sciatica pain, including difficulty moving, burning, and tingling in the legs, toes, and feet.

Fresh organic strawberries sold at multiple major retailers linked to multistate hepatitis A outbreak.

Fees are now so large that "hiding the cheese" will be harder to accomplish in a year and a half.

Tesh Khullar, co-founder and president of House Rx, discusses how social determinants of health can impact time to treatment initiation.

Managers can mitigate transition-related stress in new pharmacists by encouraging mentoring from senior staff.

Efforts to decrease hospital readmissions may have been misguided because the United States are already doing better than other high-income nations in this area.

The increased negative health outcomes associated with migraines provide an opportunity for pharmacists in both the inpatient and outpatient setting to support patients.

Analysis also shows a reduction in the need for opiate painkillers, and there was a decrease in other cancer-related symptoms, according to results published in Frontiers in Pain Research.

The medications are linked with reduced negative emotional bias, according to new research published in Biological Psychiatry.

Analysis provides new understanding of the effect of probiotics on the tiniest of infants in the neonatal intensive care.

In ECOSPOR III, the lead therapeutic candidate incorporated itself durably and rapidly into the microbiome to prevent recurrence, the company says.

Evinacumab-dgnb (Evkeeza) is indicated as an adjunct to other LDL-C lowering therapies for the treatment of homozygous familial hypercholesterolemia.

Zicam Extreme Congestion Relief treats nasal congestion and sinus pressure.

Health systems must have a flexible workflow in place to allow the use of non-preferred agents to accommodate payer demands and reduce financial toxicity.

Pharmacy Times will be covering the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting live in Chicago, Illinois, from June 3 through 7, 2022.

Tisagenlecleucel was shown to be effective in high-risk patients, including those who were heavily pretreated or had refractory disease.

We're rowing in the same direction as pharmacists, so that what is of interest to a payer, PBMs and pharmacies, according to PQA.

It is important that mental health professionals and providers look to newer approaches and methods to supplement the current standard of care.

The FreeStyle Libre 3 is the most accurate 14-day continuous glucose monitor with a 7.9% overall mean absolute relative difference and readings are sent directly to a smartphone every minute.

Hospital pharmacists can play an instrumental role in controlling the misuse of opioids while ensuring appropriate pain management for their patients.

We spoke with Kelly McAuliff, PharmD, BCOP, CSP, to learn about data being presented at the ASCO 2022 Annual Meeting.

Nivolumab (Opdivo) with fluoropyrimidine- and platinum-containing chemotherapy and nivolumab plus ipilimumab (Yervoy) approved as first-line treatments for unresectable advanced or metastatic esophageal squamous cell carcinoma.

Investigators at Loma Linda University Health saw these common denominators among both vegetarians and non-vegetarians.